Emine Afşin | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Emine Afşin | Clinical Medicine | Best Researcher Award 

Associate Professor | Bolu Abant Izzet Baysal University | Turkey

Dr. Emine Afşin is a distinguished medical professional and academic whose career reflects a deep commitment to advancing respiratory medicine and public health through clinical excellence, scientific research, and education. As an Associate Professor at Bolu Abant İzzet Baysal University, she has built a robust portfolio of contributions that span clinical practice, scholarly publications, and multidisciplinary collaborations. Her expertise lies in pulmonary diseases, clinical epidemiology, and patient-centered care, with a strong focus on improving diagnostic accuracy and therapeutic outcomes for individuals affected by chronic and infectious respiratory conditions. Dr. Afşin’s research encompasses a wide range of studies addressing disease pathophysiology, healthcare delivery, and preventive interventions, consistently demonstrating her dedication to evidence-based medicine. Her published works in reputable national and international journals have been widely cited, reflecting the impact and relevance of her findings within the global medical community. Through active participation in collaborative research projects, professional societies, and academic conferences, she has fostered strong partnerships that bridge clinical practice and scientific inquiry. Beyond academia, Dr. Afşin is recognized for her role in enhancing healthcare quality, mentoring young physicians, and advocating for equitable access to respiratory health services. Her work continues to contribute meaningfully to both medical science and society, emphasizing innovation, ethics, and human-centered approaches to healthcare advancement. She has 23 citations from 23 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID
Publications

1. Yılmazer, M., Altındiş, M., Cevrioğlu, S., Fenkci, V., Aktepe, O., & Sırthan, E. (2004). Afyon Bölgesinde yaşayan gebe kadınlarda toksoplazma, sitomegalovirus, rubella, hepatit B, hepatit C seropozitiflik oranları. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi.

2. Oğurlu, M., Sen, S., Polatli, M., Sırthan, E., Gürsoy, F., & Cildağ, O. (2007). The effect of spinal anesthesia on pulmonary function tests in old patients. Tuberkuloz ve Toraks, 55(1), 64–70.

3. Afsin, E., Yaksi, O., Onal, A., & Bacaksiz, E. (2022). Tracheal schwannoma mimicking asthma. International Journal of Neuroscience, 134(5), 436–440. https://doi.org/10.1080/00207454.2021.1999702

4. Afşin, E., & Demirkol, M. E. (2022). Post-COVID pulmonary function test evaluation. Turkish Thoracic Journal, 23(5), 345–350. https://doi.org/10.5152/TurkThoracJ.2022.22023

5.Afşin, E., & Cosgun, Z. (2021). A rare cough complication: Internal oblique muscle hematoma. Radiology Case Reports, 16(5), 1015–1018. https://doi.org/10.1016/j.radcr.2021.01.067

Tana Takacova | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.

Jian Feng | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Jian Feng | Clinical Medicine | Best Researcher Award

Doctor | The General Hospital of Western Theater Command | China

Dr. Jian Feng is an Attending Physician at the Intensive Care Unit of The General Hospital of Western Theater Command in Chengdu, Sichuan Province, China. He earned his medical degree and completed advanced training in critical care medicine, with a focus on sepsis, multiple organ failure, acute respiratory distress syndrome, and altitude sickness. Dr. Feng has led and participated in multiple provincial- and national-level research projects, including studies on ICU-acquired weakness, the role of curcumin in skeletal muscle preservation at high altitudes, and innovative interventions in critical care. He has published extensively, with over 11 SCI-indexed papers and numerous Chinese core journal articles as first or corresponding author, including high-impact works in Asian Journal of Surgery, Journal of Inflammation Research, and Frontiers in Cellular and Infection Microbiology. His contributions extend to medical innovation, holding multiple invention and utility model patents, and co-authoring the monograph Clinical Nutritional Therapy for Neurocritical Care. Dr. Feng has received recognition for his research and clinical excellence, including awards for innovation and translational medicine. Beyond his research, he serves as a reviewer for prestigious journals such as Heliyon and Medical Science Monitor, demonstrating his commitment to advancing scientific rigor and critical peer review in the field of critical care medicine. His work combines clinical expertise with innovative research, reflecting a dedication to improving patient outcomes and contributing to the scientific community at both national and international levels. He has 51 citations from 20 documents with an h-index of 4.

Profiles: Scopus | ORCID

Publications

1. Wang, M., Huang, B., Chen, J., Rui, Z., Li, J., Fang, S., Fan, L., Feng, J., & Li, F. (2025). Artificial intelligence and machine learning in the research and application status of ICU-acquired weakness.

2. Liu, J., Xu, Z., Luo, S., Bai, Y., Feng, J., & Li, F. (2024). Risk factors for ICU-acquired weakness in sepsis patients: A retrospective study of 264 patients.

3. Tan, J., Huang, B., Luo, S., Li, R., Hou, J., Zhang, R., Wang, L., Liu, Y., Li, F., & Feng, J. (2024). A rare case of severe pneumonia combined with septic shock caused by Nocardia amamiensis.

4. Luo, H., Feng, J., Xue, G., Zhang, Y., Li, Y., Huang, X., Chen, X., You, S., Dong, H., & Li, L. (2023). Comparative efficacy and acceptability of 12 phosphorus-lowering drugs in adults with hyperphosphatemia and chronic kidney disease: A systematic review and network meta-analysis.

5. Luo, S., Wang, L., Xu, Z., Liu, J., Zhang, W., Feng, J., & Li, F. (2023). Isolation, identification and biological characteristics of phage vB-KpnP1 for carbapenem-resistant Klebsiella pneumoniae.

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.